Assessment of imaging risks for recurrence after stereotactic radiosurgery for brain metastases (IRRaS-BM). Roh YH, Park JE, Park SY, Cho YH, et al. BMC Cancer 2024;24:866.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Roh YH, Park JE, Park SY, Cho YH, et al. Assessment of imaging risks for recurrence after stereotactic radiosurgery for brain metastases (IRRaS-BM). BMC Cancer 2024;24:866.
PMID: 39026289